Johnson & Johnson pauses COVID-19 vaccine trial over patient illness
Headline:
Qatar Emir’s air ambulance awaits nod for Khaleda Zia’s travel
Putin and Modi for strengthening trade, announce $100 Billion target by 2030
Survivors for urgent aid after deadly floods, landslides kill over 1,500 across Asia
Lalmonirhat celebrates the day Pakistani troops fled in 1971

Johnson & Johnson pauses COVID-19 vaccine trial over patient illness

Johnson & Johnson pauses COVID-19 vaccine trial over patient illness
Representational image


U.S. pharmaceutical company Johnson & Johnson said Monday it had paused its COVID-19 vaccine trial because one of its participants had become sick.

"We have temporarily paused further dosing in all our COVID-19 vaccine candidate clinical trials, including the Phase 3 ENSEMBLE trial, due to an unexplained illness in a study participant," the company said in a statement.

The patient's condition was being reviewed and evaluated by the ENSEMBLE independent Data Safety Monitoring Board as well as internal clinical and safety physicians, it said.

Read Also: US Man gets Covid twice, second hit 'more severe'

Subscribe UNB YouTube Channel
Johnson & Johnson COVID-19 vaccine Covid-19 vaccine trial U.S. pharmaceutical company